---  
layout: startup_page  
title: "Callio Therapeutics"  
id: "calliotx.com"  
permalink: "/calliotherapeuticscalliotx.com03032025/"  
website: "http://www.calliotx.com"  
funding_round: "Series A"  
funding_amount: "$187M"  
investors: "Frazier Life Sciences, Jeito Capital, Novo Holdings A/S, Omega Funds, ClavystBio, Platanus, Norwest, Pureos Bioventures, SEEDS Capital, EDBI"  
about: "Callio Therapeutics is a biotechnology company focused on developing multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy. The company is developing next-generation ADCs with differentiated linker and payload technologies to deliver multiple agents to tumor cells, maximizing therapeutic benefit. Their lead program is a dual-payload ADC targeting HER2."  
markets: "Biotech, Oncology, Health Care, Medical"  
hq: "Seattle, Washington, United States"  
founded_year: ""  
linkedin: "https://www.linkedin.com/company/calliotx"  
twitter: ""  
instagram: ""  
facebook: ""  
crunchbase: "https://www.crunchbase.com/organization/callio-therapeutics"  
pitchbook: "https://pitchbook.com/profiles/company/756136-18"  

date_display: "03-Mar-2025"  
date: "2025-03-03"

# SEO Optimization  
meta_title: "Callio Therapeutics - Series A Funding ($187M)"  
meta_description: "Callio Therapeutics, Callio Therapeutics is a biotechnology company focused on developing multi-payload antibody-drug conjugates (ADCs) to improve cancer therapy. The comp..."  
meta_keywords: "Callio Therapeutics, Biotech, Oncology, Health Care, Medical, Series A funding"  
canonical_url: "https://startup.projectstartups.com/calliotherapeuticscalliotx.com03032025/"  
---